POWELL FRED M (Executive Vice President & CFO) received a stock award from ANTARES PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/18/2022ACC: 0001016169-22-000014
Officer· Executive Vice President & CFO
Since Jun 2019
+13.11K
Net shares
Net buyer
$42.1K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
24.61K acquired · 11.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+24.61K
Price / share
—
Trade value
—
% of position
3.2%
2/16/2022
761.65K→786.26K
Common Stock
Direct
Shares
−11.50K
Price / share
$3.66
Trade value
$42.08K
% of position
1.5%
2/16/2022
786.26K→774.76K
Total
Net shares
+13.11K
Net value
-$42.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/16/2022 | A · Award | +24.61K | — | — | 3.2% | 761.65K | 786.26K |
| Common Stock Direct | 2/16/2022 | F · Tax Withholding | −11.50K | $3.66 | $42.08K | 1.5% | 786.26K | 774.76K |
| Total | +13.11K | -$42.08K | ||||||
Derivative Transactions0
No derivative transactions reported